Imbed Biosciences

About:

Imbed Biosciences is a Privately held medical device company.

Website: http://www.imbedbio.com

Twitter/X: imbedbio

Top Investors: National Science Foundation, Wisconsin Economic Development, Small Business Innovation Research, MassChallenge, Niterra Ventures

Description:

Imbed Biosciences, Inc, (“Imbed”) is a privately held medical device company developing novel and patent-pending technologies for imbedding bioactive molecules in wound dressings and surgical implants. By leveraging its novel biomaterials platforms, Imbed is revolutionizing wound dressings to prevent wound infections and expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds, a $3 billion market opportunity in the U.S. and Europe. Imbed is a spin-off from the University of Wisconsin-Madison, based on 4 years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Collectively, the founders bring more than 25 years of experience in clinical wound management.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fitchburg, Wisconsin, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)imbedbio.com

Founders:

Ankit Agarwal, Nicholas Abbott

Number of Employees:

11-50

Last Funding Date:

2024-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai